Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **lysosomal membrane in antigen-presenting cells (APCs)** is the lipid bilayer that surrounds the lysosome, a key organelle responsible for the degradation and processing of exogenous antigens. This membrane contains integral membrane proteins such as LAMP1, LAMP2, LIMP2, and SNAREs, which together regulate: - protection from self-degradation by lysosomal enzymes - acidification of the lumen for hydrolase activity via V-ATPase - vesicle trafficking, fusion, and antigen presentation pathways In APCs, lysosomes are dynamically involved in the processing of internalized antigens into peptides, which are loaded onto MHC class II molecules for subsequent presentation to T cells, a critical step in adaptive immunity. The lysosomal membrane machinery also supports fusion with phagosomes/endosomes and recycling of biomolecules. Lysosomal dysfunction or loss of membrane integrity disrupts antigen processing, immune responses, and can promote autoimmunity, neurodegeneration, or lysosomal storage diseases.
Not applicable for the membrane structure; drugs may disrupt lysosomal acidification or membrane fusion indirectly
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lysosomal membrane (in antigen-presenting cell) (null).